JESSICA MAMULA: Open Payments
NPI 1679043319 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 11 payments from 5 companies in 2025. Trend: 2023 $216 · 2024 $142 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $185 |
| Janssen Pharmaceuticals, Inc | 1 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $97 |
| ABBVIE INC. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
Products named: INVEGA SUSTENNA, CAPLYTA, VRAYLAR, INGREZZA, TRINTELLIX.
Industry payments across CO — which companies pay providers there.
